एपीए उद्धरण

Al-Ahmadie, H., Iyer, G., Hohl, M., Asthana, S., Inagaki, A., Schultz, N., . . . Taylor, B. S. (2014). Synthetic lethality in ATM-deficient RAD50-mutant tumors underlie outlier response to cancer therapy.

शिकागो स्टाइल उद्धरण

Al-Ahmadie, Hikmat, et al. Synthetic Lethality in ATM-deficient RAD50-mutant Tumors Underlie Outlier Response to Cancer Therapy. 2014.

एमएलए उद्धरण

Al-Ahmadie, Hikmat, et al. Synthetic Lethality in ATM-deficient RAD50-mutant Tumors Underlie Outlier Response to Cancer Therapy. 2014.